« Back to Record
Citation APA

Lambertini, M., Martel, S., Campbell, C., Guillaume, S., Hilbers, F. F., Schuehly, U., Korde, L., Abdel Azim, H. H., Di Cosimo, S., Tenglin, R. R., Huober, J., Baselga, J., Moreno-Aspitia, A., Piccart-Gebhart, M., Gelber, R. D., de Azambuja, E., & Ignatiadis, M. (2018). Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. Cancer. doi:10.1002/cncr.31784


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/278355

Lambertini, M., Martel, S., Campbell, C., Guillaume, S., Hilbers, F. F., Schuehly, U., Korde, L., Abdel Azim, H. H., Di Cosimo, S., Tenglin, R. R., Huober, J., Baselga, J., Moreno-Aspitia, A., Piccart-Gebhart, M., Gelber, R. D., de Azambuja, E., & Ignatiadis, M. (2018). Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. Cancer. doi:10.1002/cncr.31784